A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety
Table 4
Adverse Events (AE).
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Adverse Events (AE).